HIGHLIGHTS
- who: Giovanni Barosi from the Center for the have published the article: Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives, in the Journal: (JOURNAL) of 23/Dec/2022
- what: Distinguishing features of the new variants the authors propose are of considerable clinical import.
SUMMARY
None of the 15 subjects with CMD-NBV had signs of disease progression after a median follow-up of more than 8 years, Subjects with CMD-IT lived longer than those with pre-fibrotic MF and those . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.